H.R.1794 - United States-Abraham Accords Cooperation and Security Act of 2025 (119th Congress)
Summary
H.R.1794, the United States-Abraham Accords Cooperation and Security Act of 2025, aims to enhance cooperation with Abraham Accords countries in the realm of food and drug regulation. The bill directs the FDA to establish an Abraham Accords Office to provide technical assistance and facilitate interactions with regulatory partners in those countries. This includes strengthening regulatory oversight and converging regulatory requirements for medical products.
Expected Effects
The bill's enactment would lead to the creation of a new office within the FDA focused on collaboration with Abraham Accords countries. This office would provide technical assistance and facilitate information sharing, potentially leading to improved regulatory standards and increased trade in regulated commodities. A report to Congress will be required after three years to evaluate the office's effectiveness.
Potential Benefits
- Enhanced Regulatory Standards: Could lead to improved safety and quality of medical products in Abraham Accords countries.
- Increased Trade: Facilitating regulatory convergence may promote trade in regulated commodities.
- Strengthened International Relations: Fosters cooperation with key allies in the Middle East.
- Knowledge Sharing: Provides a platform for sharing best practices in food and drug regulation.
- Improved Public Health: Ultimately aims to improve public health outcomes through better regulation.
Potential Disadvantages
- Bureaucratic Expansion: Creates a new office within the FDA, potentially increasing bureaucracy.
- Resource Allocation: May divert resources from other important FDA activities.
- Potential for Conflicts of Interest: Could create opportunities for undue influence from Abraham Accords countries.
- National Security Concerns: While the bill includes a national security clause, there is still potential for sensitive information to be shared.
- Limited Scope: The benefits are limited to countries that are part of the Abraham Accords, potentially excluding other important partners.
Constitutional Alignment
The bill appears to align with the Constitution, particularly the implied powers granted to Congress under Article I, Section 8, which allows Congress to regulate commerce with foreign nations. The establishment of an office within the FDA to promote cooperation with other countries on regulatory matters falls within this purview. There are no apparent violations of individual rights or freedoms guaranteed by the Bill of Rights.
Impact Assessment: Things You Care About ⓘ
This action has been evaluated across 19 key areas that matter to you. Scores range from 1 (highly disadvantageous) to 5 (highly beneficial).